AVP response to LBNP is attenuated in a hyperbaric environment

Prior research has shown that hyperbaric conditions influence hormonal responses in humans. Established knowledge includes the role of arginine vasopressin (AVP) in maintaining fluid balance during stress. However, no prior work had resolved how hyperbaria specifically affects AVP release during hypovolemic stress. This gap motivated a focused investigation into AVP dynamics under controlled environmental pressures. Existing studies suggest AVP is sensitive to osmolality and blood volume shifts. Yet, the interplay between hyperbaria and AVP remains unclear. The current paper introduces a novel approach to test AVP response in a hyperbaric setting. This study adds clarity to how environmental pressure modulates AVP secretion during hypovolemia.

The aim of this study was to determine if hyperbaria alters AVP release during central hypovolemic stress. The specific problem addressed is the potential attenuation of AVP response in high-pressure environments. The motivation stems from prior findings that hyperbaria influences hormonal regulation. This study tests the hypothesis that AVP response is reduced in hyperbaric conditions. The focus is on AVP's reaction to lower-body negative pressure (LBNP). The study compares AVP levels at 1 and 3 atmosphere absolute (ATA) pressures. Researchers sought to isolate the effect of pressure from other variables like osmolality. The goal is to clarify if hyperbaria alone dampens AVP secretion during stress.

The study used a controlled experimental design with 10 male participants. Participants underwent LBNP at -20 and -40 mmHg at 1 and 3 ATA. Blood samples were collected to measure plasma AVP and norepinephrine (NE). Thoracic impedance (Z0) and leg volume were also monitored. Measurements were taken during control and stress conditions. The protocol included 4-minute intervals for each pressure level. Environmental pressure was manipulated using a hyperbaric chamber. Data collection focused on AVP, NE, osmolality, hematocrit, and Z0 changes.

AVP levels increased significantly at -40 mmHg LBNP at 1 ATA but not at 3 ATA. At 1 ATA, AVP rose from 0.9 to 1.8 pg x ml(-1) during LBNP. At 3 ATA, the increase was smaller, from 0.9 to 1.2 pg x ml(-1). Baseline NE levels were 22.4 pg x ml(-1) lower at 3 ATA than at 1 ATA. NE increased with LBNP at both pressures but not due to pressure differences. Thoracic impedance changes were identical at both pressures. Plasma osmolality and hematocrit remained stable throughout the experiment. Leg volume increased with LBNP but similarly at both pressures. These findings indicate hyperbaria dampens AVP and NE responses to hypovolemia.

The authors propose that hyperbaria attenuates AVP and NE responses to hypovolemic stress. These findings suggest a direct effect of pressure on hormonal regulation. No prior work had resolved if pressure alone influences AVP secretion. The study shows AVP changes are not due to osmolality or thoracic blood shifts. The results support the hypothesis that hyperbaria reduces AVP release during LBNP. The authors conclude that pressure modulates AVP and NE independently of other factors. These conclusions align with prior evidence on hyperbaric effects on hormones. The study does not claim broader implications beyond the observed AVP and NE responses.